Urocortin and corticotrophin-releasing hormone receptor type 2 mRNA are highly expressed in deep infiltrating endometriotic lesions
article
OA: closed
CC0
⤵ 26 in-corpus citations
AI-generated summary
Urocortins and corticotrophin-releasing hormone receptor type 2 mRNA were found to be highly expressed in deep infiltrating endometriotic lesions.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Ovarian endometrioma (OMA) and deep infiltrating endometriosis (DIE) are the most severe forms of endometriosis, but different pathogenetic mechanisms and clinical symptoms distinguish these two forms. Corticotrophin-releasing hormone (CRH) and urocortin (Ucn) are endometrial neuropeptides involved in tissue differentiation and inflammation. The expression of CRH, Ucn, Ucn2, CRH-receptors (type-1 and type-2) and inflammatory enzymes phospholipase-A2 group IIA (PLA2G2A) and cycloxygenase-2 (COX2) were evaluated in OMA (n = 22) and DIE (n = 26). The effect of CRH or Ucn on COX2 mRNA expression was evaluated in cultured human endometrial stromal cells. In DIE lesions, CRH, Ucn and CRH-R2 mRNA levels were significantly higher than in OMA (P < 0.01, P < 0.001 and P < 0.05, respectively); DIE lesions showed a higher expression of COX2 (P < 0.01) and PLA2G2A (P < 0.05) mRNA than OMA, which was positively correlated with CRH-R2 mRNA expression (P < 0.05). Intense immunostaining for CRH and Ucn was shown in DIE. Treatment of cultured endometrial stromal cells with Ucn significantly increased COX2 mRNA expression (P < 0.01); this effect was reversed by the CRH-R2 antagonist astressin-2B. In DIE, DIE lesions highly express neuropeptide and enzyme mRNAs, supporting a strong activation of inflammatory pathways.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (56)
- An update on the pharmacological management of endometriosis via openalex
- Central changes associated with chronic pelvic pain and endometriosis via openalex
- Deep endometriosis infiltrating the recto-sigmoid: critical factors to consider before management via openalex
- Deep infiltrating endometriosis: relation between severity of dysmenorrhoea and extent of disease via openalex
- Differential Expression of CRH, UCN, CRHR1 and CRHR2 in Eutopic and Ectopic Endometrium of Women with Endometriosis via openalex
- Distribution of cyclooxygenase-2 in eutopic and ectopic endometrium in endometriosis and adenomyosis via openalex
- Dual suppression of estrogenic and inflammatory activities for targeting of endometriosis via openalex
- Endometriosis via openalex
- Endometriosis: hormone regulation and clinical consequences of chemotaxis and apoptosis via openalex
- Expression of eicosanoid biosynthetic and catabolic enzymes in peritoneal endometriosis via openalex
- Expression of Nodal, Cripto, SMAD3, Phosphorylated SMAD3, and SMAD4 in the Proliferative Endometrium of Women With Endometriosis via openalex
- Hormonal Therapy Deregulates Prostaglandin-Endoperoxidase Synthase 2 (<i>PTGS2</i>) Expression in Endometriotic Tissues via openalex
- Increased expression of antimüllerian hormone and its receptor in endometriosis via openalex
- Inflammation and nerve fiber interaction in endometriotic pain via openalex
- Inflammatory Status Influences Aromatase and Steroid Receptor Expression in Endometriosis via openalex
- New principles in the management of endometriosis. via openalex
- New trends for the medical treatment of endometriosis via openalex
- Oral contraceptives and endometriosis: the past use of oral contraceptives for treating severe primary dysmenorrhea is associated with endometriosis, especially deep infiltrating endometriosis via openalex
- Ovarian endometrioma: severe pelvic pain is associated with deeply infiltrating endometriosis via openalex
- Pathogenetic Mechanisms of Deep Infiltrating Endometriosis via openalex
- Peripheral changes in endometriosis-associated pain via openalex
- Phospholipase A2 group IIA is elevated in endometriomas but not in peritoneal fluid and serum of ovarian endometriosis patients via openalex
- Plasma Urocortin Levels in the Diagnosis of Ovarian Endometriosis via openalex
- Protein oxidative stress markers in peritoneal fluids of women with deep infiltrating endometriosis are increased via openalex
- Serum and peritoneal interleukin-33 levels are elevated in deeply infiltrating endometriosis via openalex
- Surgical treatment affects perceived stress differently in women with endometriosis: correlation with severity of pain via openalex
- The dynamics of nuclear receptors and nuclear receptor coregulators in the pathogenesis of endometriosis via openalex
- The Endometriotic Tissue Lining the Internal Surface of Endometrioma: Hormonal, Genetic, Epigenetic Status, and Gene Expression Profile via openalex
- The Relationship Among HOXA10, Estrogen Receptor α, Progesterone Receptor, and Progesterone Receptor B Proteins in Rectosigmoid Endometriosis: A Tissue Microarray Study via openalex
- Transforming Growth Factor β1 Gene Polymorphism —509C/T in Deep Infiltrating Endometriosis via openalex
- Ultrasound mapping system for the surgical management of deep infiltrating endometriosis via openalex
- Urocortin 2 and urocortin 3 in endometriosis: evidence for a possible role in inflammatory response via openalex
- Whole genome deoxyribonucleic acid microarray analysis of gene expression in ectopic versus eutopic endometrium via openalex
- W6721182183 via openalex
- W1583240007 via openalex
- W1966449090 via openalex
- W1973355249 via openalex
- W1983264291 via openalex
- W2021744799 via openalex
- W2033247060 via openalex
- W2049801235 via openalex
- W2085630652 via openalex
- W2097972396 via openalex
- W2118201837 via openalex
- W2120919525 via openalex
- W2134848914 via openalex
- W2151119872 via openalex
- W2152703367 via openalex
- W2155890714 via openalex
- W2196616495 via openalex
- W2291960606 via openalex
- W2411833977 via openalex
- W2477008945 via openalex
- W6654175549 via openalex
- W6714893926 via openalex
- W78459228 via openalex
Cited by (26)
- Regional homogeneity alterations reflect pain and emotional dysregulation in adenomyosis 2026
- Endometrial Stromal Cell Senescence: A Non‐Negligible Factor in Recurrent Pregnancy Loss 2026
- Neuroendocrine-Immune Axis in Endometriosis: A Review on How the Nervous System Goes Beyond Pain Perception 2025
- β-Adrenoreceptors types 1 and 2 in the diagnosis of pain syndrome in patientswith various forms of adenomyosis 2025
- Urinary Urocortin as a Potential Non-Invasive Biomarker in Endometriosis: Exploratory Study with Histone H4 2025
- Cytotoxic T Lymphocytes, Tc17 Cells, Th1 Cells, and ThGM Cells are Increased in the Blood and Ectopic Endometrium of Patients With Adenomyosis 2024
- Role of neuropeptides in patients with endometriosis: a literature review 2024
- THE ROLE OF CHRONIC INFLAMMATION IN BENIGN PROLIFERATIVE DISEASES OF THE MYOMETRIUM 2024
- Sphingosine 1-phosphate elicits a ROS-mediated proinflammatory response in human endometrial stromal cells via ERK5 activation 2023
- Possible Correlation between Urocortin 1 (Ucn1) and Immune Parameters in Patients with Endometriosis 2023
- Biomarkers of endometriosis 2023
- Transcriptomic analysis supports collective endometrial cell migration in the pathogenesis of adenomyosis 2022
- Insights on Adenomyosis Development 2022
- Mechanisms and Pathogenesis of Adenomyosis 2022
- Is primary dysmenorrhea a precursor of future endometriosis development? 2021
- Endometriosis: New Perspective for the Diagnosis of Certain Cytokines in Women and Adolescent Girls, as Well as the Progression of Disease Outgrowth: A Systematic Review 2021
- Celecoxib reduces inflammation and angiogenesis in mice with adenomyosis. 2021
- An integrated approach to the treatment of pelvic pain associated with adenomyosis 2021
- The Link Between Stress and Endometriosis: from Animal Models to the Clinical Scenario 2020
- Common and specific gene signatures among three different endometriosis subtypes 2020
- Adenomyosis: Mechanisms and Pathogenesis 2020
- Hormones and Inflammation: An Update on Endometriosis 2019
- Urocortin Expression in Endometriosis: A Systematic Review. 2019
- Increased expression of neurogenic factors in uterine fibroids 2019
- Endometrial CRH and implantation: from bench to bedside 2018
- Plasma urocortin-1 as a preoperative marker of endometriosis in symptomatic women 2017
Source provenance
- europepmc
- last seen: 2026-09-16T06:11:32.772430+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:20:54.390225+00:00
- unpaywall
- last seen: 2026-09-16T06:28:21.314993+00:00
License: CC0
· commercial use OK